Skip to main content

Table 1 Baseline characteristics of study participants (n=39)

From: Treatment of urinary incontinence in women with chronic obstructive pulmonary disease—a randomised controlled study

Baseline

All participants

n=39

PFMT group

n=7

CST group

n=12

Control group

n=10

Non-completers

n=10

Age (years)

66.4±7.9

67.6±5.5

67.9±5.4

63.9±12.3

66.3±6.9

Current smokers, n (%)

12 (31)

1 (14)

4 (33)

5 (50)

2 (20)

Nullipara, n (%)

5 (13)

0 (0)

1 (8)

3 (30)

1 (10)

Parity

2.0±1.1

2.3±0.5

2.2±0.9

1.8±1.7

1.8±0.9

UI duration (years)

10.8±11.5

9.7±10.9

9.4±11.9

10.3±11.7

13.2±12.9

FEV1 (% pred.)

52.7± 16.8

50.9±12.8

52.0±17.1

57.9±18.9

49.0±18.2

FVC (% pred.)

78.9±14.7

82.7±10.4

75.2±16.5

85.2±16.5

75.1±14.2

GOLD class, n (%)

     

 I

6 (15)

1 (14)

3 (25)

2 (20)

0 (0)

 II

15 (39)

2 (29)

2 (17)

5 (50)

6 (60)

 III

13 (33)

3 (43)

6 (50)

3 (30)

1 (10)

 IV

3 (8)

1 (14)

0 (0)

0 (0)

2 (20)

 Missing

2 (5)

0 (0)

1 (8)

0 (0)

1 (10)

6MWD (m)

383±112

382±97

375±160

388±88

387±84

Steps/day

3563±3063

3565±1732

2439±2460

4449±3434

4118±4374

CAT total score

22.1±6.8

24.1±5.7

20.6±6.8

25.5±5.7

18.9±7.2

ICIQ-UI SF total score

9.6±4.3

8.9±4.3

7.3±4.6

11.4±2.8

11.1±4.3

LCQ total median (IQR)

16.0 (14.0–18.8)

15.0 (14.0–20.0)

15.0 (12.8–18.0)

17.0 (13.0–18.2)

18.0 (15.5–20.5)

  1. Data are presented as mean ± SD otherwise stated. PFMT pelvic floor muscle training, CST cough-suppression therapy, FEV1 forced expiratory volume in 1 second, FVC forced vital capacity, GOLD Global Initiative for Chronic Obstructive Lung Disease, 6MWD six-minute walk distance, CAT COPD Assessment Test, ICIQ-UI SF International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form, LCQ Leicester Cough Questionnaire, IQR interquartile range